COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review.

Aline Pereira da Rocha Alvaro Nagib Atallah Ana Carolina Pereira Nunes Pinto César Ramos Rocha-Filho Keilla Machado Martins Milby Vinicius Tassoni Civile Nelson Carvas Junior Felipe Sebastião de Assis Reis Laura Jantsch Ferla Gabriel Sodré Ramalho Giulia Fernandes Moça Trevisani Maria Eduarda Dos Santos Puga Virgínia Fernandes Moça Trevisani

Published in: Sao Paulo medical journal = Revista paulista de medicina (2020)

Patients undergoing pharmacological treatment for IMID seem to present higher chances of requiring admission to ICUs, with IMV. Additional high-quality studies are needed to analyze the effects of different treatments for IMID.

Keyphrases

systematic review
patients undergoing
coronavirus disease
sars cov
meta analyses
emergency department
oxidative stress
randomized controlled trial
respiratory syndrome coronavirus
replacement therapy